IL-2 SELECTIVE AGONISTS AND ANTAGONISTS

The invention is directed to a polypeptide comprising a human IL-2 mutein numbered in accordance with wild-type IL-2 wherein said human IL-2 is substituted at at least one of positions 20, 88 or 126, whereby said mutein preferentially activates T cells over NK cells. D20H and I, N88G, I, and R, in p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GREVE JEFFREY M, SHANAFELT ARMEN B, JESMOK GARY, WETZEL GAYLE D, LEMBACH KENNETH J
Format: Patent
Sprache:eng ; pol
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!